← Back to Search

Regenerative Medicine

3D Reconstruction Planning for Nasal Surgery

N/A
Recruiting
Led By Brittany Howard, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients undergoing nasal reconstruction
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to plan surgeries to reconstruct patients' noses, using 3D scanning and printing instead of the standard method.

Who is the study for?
This trial is for men and women aged 18 to 100 who are planning to undergo nasal reconstruction. They must be patients from the Facial Plastic Surgery clinic of the Principal Investigator. Children under 18 are excluded due to shared postoperative follow-up with pediatric providers.
What is being tested?
The study aims to compare traditional nasal reconstruction planning methods with a new approach using preoperative scanning, printing, and planning in three dimensions (3D) for safety and effectiveness.
What are the potential side effects?
Since this trial focuses on comparing surgical planning techniques rather than medications, side effects may relate more to potential complications or differences in surgery outcomes between standard and 3D planned reconstructions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for nasal reconstruction surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Viable nasal reconstruction
Secondary study objectives
Nasal breathing

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 3D Nasal Reconstruction PlanningExperimental Treatment1 Intervention
Subjects undergoing nasal reconstruction will have 3D planning utilized by the surgical team for the procedure.
Group II: Standard of Care Nasal Reconstruction PlanningActive Control1 Intervention
Subjects undergoing nasal reconstruction will have standard planning for procedure.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,362 Previous Clinical Trials
3,066,094 Total Patients Enrolled
1 Trials studying Nasal Surgery
60 Patients Enrolled for Nasal Surgery
Brittany Howard, MDPrincipal InvestigatorMayo Clinic

Media Library

3D Nasal Reconstruction Planning (Regenerative Medicine) Clinical Trial Eligibility Overview. Trial Name: NCT05273060 — N/A
Nasal Surgery Research Study Groups: Standard of Care Nasal Reconstruction Planning, 3D Nasal Reconstruction Planning
Nasal Surgery Clinical Trial 2023: 3D Nasal Reconstruction Planning Highlights & Side Effects. Trial Name: NCT05273060 — N/A
3D Nasal Reconstruction Planning (Regenerative Medicine) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05273060 — N/A
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top